Propiedad y actividad de insiders de Catalyst Pharmaceuticals, Inc. (CPRX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $31.49 |
| Capitalización | $3.9B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-07-15 | Elsbernd Brian | D-Return | 242,501 | $7.6M |
| 2026-07-15 | Elsbernd Brian | D-Return | 132,000 | $612K |
| 2026-07-15 | Elsbernd Brian | D-Return | 200,000 | $684K |
| 2026-07-15 | Elsbernd Brian | D-Return | 135,000 | $954K |
| 2026-07-15 | Elsbernd Brian | D-Return | 69,000 | $1.3M |
| 2026-07-15 | Elsbernd Brian | D-Return | 147,621 | $2.1M |
| 2026-07-15 | Elsbernd Brian | D-Return | 126,704 | $2.7M |
| 2026-07-15 | Elsbernd Brian | D-Return | 98,652 | $2.2M |
| 2026-07-15 | Elsbernd Brian | D-Return | 29,776 | |
| 2026-07-15 | Curran Daniel J. | D-Return | 40,000 | $845K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $13.9M | $57.5M | $16.6M | $89.5M | $130.2M | $171.4M | $298.4M | $137.6M | $517.6M | $709.2M |
| Inversiones a Corto | $26.5M | $26.5M | $36.9M | $5.0M | $10.0M | $19.8M | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $10.5M | $6.0M | $6.7M | $10.8M | $53.5M | $65.5M | $128.3M |
| Inventario | 0 | 0 | $56012 | $2.0M | $4.7M | $7.9M | $6.8M | $15.6M | $19.5M | $37.2M |
| Activos Corrientes | $41.5M | $85.2M | $55.2M | $111.4M | $159.2M | $210.1M | $320.8M | $219.3M | $623.6M | $894.0M |
| Inmovilizado Material | $244204 | $191385 | $245425 | $1.0M | $130000 | $4.0M | $3.6M | $3.7M | $3.6M | $3.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | $32.5M | $194.0M | $156.7M | $131.7M |
| Activos Totales | $41.7M | $85.4M | $60.4M | $112.4M | $192.4M | $237.8M | $375.6M | $470.1M | $851.4M | $1.11B |
| Cuentas por Pagar | $933176 | $1.9M | $2.3M | $4.1M | $4.3M | $2.8M | $4.0M | $14.8M | $16.6M | $11.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $437000 |
| Pasivos Corrientes | $2.1M | $4.3M | $9.5M | $24.1M | $22.8M | $27.1M | $57.6M | $76.1M | $120.7M | $147.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.4M | $4.4M | $9.7M | $24.7M | $22.8M | $31.0M | $75.2M | $82.2M | $123.8M | $152.5M |
| Reservas | -$108.1M | -$126.6M | -$160.6M | -$128.7M | -$53.7M | -$26.3M | $49.9M | $121.3M | $285.2M | $474.2M |
| Patrimonio Neto | $39.3M | $81.0M | $50.8M | $87.6M | $169.6M | $206.8M | $300.4M | $387.9M | $727.6M | $954.3M |
| Deuda Total | 0 | 0 | 0 | $948050 | $29000 | $4.2M | $3.9M | $3.6M | $3.2M | $2.8M |
| Deuda Neta | -$40.4M | -$84.0M | -$53.5M | -$93.6M | -$140.2M | -$187.1M | -$294.5M | -$134.1M | -$514.4M | -$706.4M |
| Capital Circulante | $39.4M | $80.9M | $45.7M | $87.3M | $136.5M | $183.0M | $263.2M | $143.3M | $502.9M | $746.9M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 7.10 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 13.94 |
Rentabilidad
| Rentabilidad sobre capital | 23.65% |
| Rentabilidad sobre capital invertido | 19.67% |
| Rentabilidad sobre activos | 19.29% |
| Margen bruto | 82.32% |
| Margen operativo | 44.83% |
| Margen neto | 37.08% |
Empresas relacionadas: AMLX · AXSM · EXEL · MDGL · TLPH · VKTX · VSTM
Explorar sector: Healthcare · Biotechnology
Más secciones de CPRX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones